Funding for this research was provided by:
The PINNACLE study was sponsored and funded by Urotronic Inc., a subsidiary of Laborie Medical Technologies Corp. (Plymouth, MN), the manufacturer of Optilume.
Article History
Received: 26 February 2024
Revised: 29 March 2024
Accepted: 9 April 2024
First Online: 29 April 2024
Competing interests
: The authors report the following conflicts of interest: SAK is the study principal investigator for the PINNACLE Study.